What are the Ebola vaccines under research, and when will they be ready?
An Ebola epidemic, triggered by the rare Bundibugyo virus, is rapidly spreading in East Africa, originating in the eastern Democratic Republic of Congo (DRC) and reaching neighboring Uganda. The World Health Organization declared a public health emergency due to the outbreak, which has infected hundreds and caused dozens of deaths. Unlike previous epidemics caused by the Zaire strain, for which approved vaccines exist, there is currently no approved vaccine for the Bundibugyo virus. This is partly because outbreaks of this strain are infrequent, limiting research opportunities. However, three vaccines are now being fast-tracked for research and trials. Experts warn that ongoing conflict in the DRC and funding cuts are hindering containment efforts, making the outlook for this epidemic concerning.